INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Globally, Coronary artery disease is one of the most common health problems. the lipid profile is one of the major risk factors for worsening the condition. This study evaluated the lipid profile of patients with Coronary artery disease who were being treated with lipid-lowering agents with the aim of reducing the risk of heart attacks and improving their health outcomes. I have investigated that Mono therapy of Atorvastatin 40mg effectively reduces LDL-C levels with fewer side effects. The complete blood analysis of 74 patients was monitored with the standard reference range. Among 74 patients, 18.5 % (n= 25) of the subjects have shown Low-density lipids, 14.8% (n=20) are total cholesterol, 14.6% (n=19) are the patients with triglycerides & 2.2 % (n=3) with elevated VLDL & 5.1% (n=7) shows the status of the HDL cholesterol. The study procedures were conducted by the ethical principles of the Declaration of Helsinki and its amendments with the CDSCO recommendations, the Indian Council of Medical Research, and GCP guidelines.
"Lipid profile in coronary artery disease under the treatment of lipid lowering agents ", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 8, page no.642 - 648, August-2023, Available :http://www.ijsdr.org/papers/IJSDR2308094.pdf
Downloads:
000338720
Publication Details:
Published Paper ID: IJSDR2308094
Registration ID:208246
Published In: Volume 8 Issue 8, August-2023
DOI (Digital Object Identifier):
Page No: 642 - 648
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn